GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » COGS-to-Revenue

Albert Labs International (XCNQ:ABRT) COGS-to-Revenue : 0.00 (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International COGS-to-Revenue?

Albert Labs International's Cost of Goods Sold for the three months ended in Sep. 2023 was C$0.00 Mil. Its Revenue for the three months ended in Sep. 2023 was C$0.00 Mil.

Albert Labs International's COGS to Revenue for the three months ended in Sep. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Albert Labs International's Gross Margin % for the three months ended in Sep. 2023 was N/A%.


Albert Labs International COGS-to-Revenue Historical Data

The historical data trend for Albert Labs International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International COGS-to-Revenue Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
COGS-to-Revenue
- -

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Albert Labs International COGS-to-Revenue Calculation

Albert Labs International's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Albert Labs International's COGS to Revenue for the quarter that ended in Sep. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International  (XCNQ:ABRT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Albert Labs International's Gross Margin % for the three months ended in Sep. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Albert Labs International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Albert Labs International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines